Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Residual cardiovascular risk.
Ferrari R, Catapano AL. Ferrari R, et al. Among authors: catapano al. Eur Heart J Suppl. 2016 Apr 12;18(Suppl C):C1. doi: 10.1093/eurheartj/suw010. Eur Heart J Suppl. 2016. PMID: 28533704 No abstract available.
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy.
Aguiar C, Alegria E, Bonadonna RC, Catapano AL, Cosentino F, Elisaf M, Farnier M, Ferrières J, Filardi PP, Hancu N, Kayikcioglu M, Mello E Silva A, Millan J, Reiner Ž, Tokgozoglu L, Valensi P, Viigimaa M, Vrablik M, Zambon A, Zamorano JL, Ferrari R. Aguiar C, et al. Among authors: catapano al. Atheroscler Suppl. 2015 Sep;19:1-12. doi: 10.1016/S1567-5688(15)30001-5. Atheroscler Suppl. 2015. PMID: 26315511
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.
Ferrari R, Aguiar C, Alegria E, Bonadonna RC, Cosentino F, Elisaf M, Farnier M, Ferrières J, Filardi PP, Hancu N, Kayikcioglu M, Mello E Silva A, Millan J, Reiner Ž, Tokgozoglu L, Valensi P, Viigimaa M, Vrablik M, Zambon A, Zamorano JL, Catapano AL. Ferrari R, et al. Among authors: catapano al. Eur Heart J Suppl. 2016 Apr 12;18(Suppl C):C2-C12. doi: 10.1093/eurheartj/suw009. Eur Heart J Suppl. 2016. PMID: 28533705
Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention.
Hoogeveen RM, Pereira JPB, Nurmohamed NS, Zampoleri V, Bom MJ, Baragetti A, Boekholdt SM, Knaapen P, Khaw KT, Wareham NJ, Groen AK, Catapano AL, Koenig W, Levin E, Stroes ESG. Hoogeveen RM, et al. Among authors: catapano al. Eur Heart J. 2020 Nov 1;41(41):3998-4007. doi: 10.1093/eurheartj/ehaa648. Eur Heart J. 2020. PMID: 32808014 Free PMC article.
The year in cardiovascular medicine 2021: dyslipidaemia.
Tokgozoglu L, Orringer C, Ginsberg HN, Catapano AL. Tokgozoglu L, et al. Among authors: catapano al. Eur Heart J. 2022 Feb 22;43(8):807-817. doi: 10.1093/eurheartj/ehab875. Eur Heart J. 2022. PMID: 34974612
Targeted proteomics improves cardiovascular risk prediction in secondary prevention.
Nurmohamed NS, Belo Pereira JP, Hoogeveen RM, Kroon J, Kraaijenhof JM, Waissi F, Timmerman N, Bom MJ, Hoefer IE, Knaapen P, Catapano AL, Koenig W, de Kleijn D, Visseren FLJ, Levin E, Stroes ESG. Nurmohamed NS, et al. Among authors: catapano al. Eur Heart J. 2022 Apr 19;43(16):1569-1577. doi: 10.1093/eurheartj/ehac055. Eur Heart J. 2022. PMID: 35139537 Free PMC article.
606 results